The government has announced a continuation of the ban on puberty blocking drugs which will prevent the sale or supply of the medication those under 18 who are not already on the drugs.
The department of health and social care announced on November 6 the renewal of a temporary ban on the sale and supply of puberty-suppressing hormones, known as ‘puberty blockers.’
Even if the drugs are prescribed by private UK-registered prescribers for gender incongruence or dysphoria, they will not be able to continue prescribing to under 18s not already taking them.
It also prevents the sale and supply of the medicines from prescribers registered in the European Economic Area or Switzerland for any purposes to those under 18.
The legislation is The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Emergency Prohibition) (Extension) (No. 2) Order 2024.
If people are unsure how the ban applies to their circumstances, further information is available from the National Referral Support Service for NHS Children and Young People’s Gender Services.
